page contents

Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs

Shutterstock photo

Nasdaq: What is the current market environment for biotech initial public offerings and biotech listings overall?

Saxe: I expect that 2018 will demonstrate positive momentum for biotech listings overall, and specifically on Nasdaq. We predict 30-plus biotech IPOs this year and a strong first half of 2018 performance leading into midterm elections. Overall, the biotec…
Latest Articles in

Leave a Reply

Your email address will not be published. Required fields are marked *


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.